On December 11, 2025, HC Wainwright & Co. maintained a Buy recommendation for Panacea Acquisition – Equity Warrant (NYSE:NUVB.WS). The average one-year price target for the security is $0.37 per share, indicating a potential upside of 34.18% from its last reported closing price of $0.27 per share.
As of the latest reports, 27 funds or institutions hold positions in NUVB.WS, a decrease of 3.57% from the previous quarter. Institutional ownership decreased by 2.77% to 4.24 million shares over three months, while the average portfolio weight among these funds rose to 0.01%, up by 0.55%.
